Response to ASX Price Query
Filed with ASX · · 4 pages · English
Re: CLINUVEL PHARMACEUTICALS LTD (“CUV”):Response to Price Query Dear Mrs Kostopoulos, We refer to your letter dated 05 November 2021, notingthe change in the price of CUV’s securities from ahigh of $40.56 to a low of $33.58 and the significant increase in the volume of CUV’s securities traded.We respond to your questions as follows: 1. CUV is not aware of any information concerning it that has no
Clinuvel Pharmaceuticals Limited on 6ix
In the deck
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL Delivers Record Revenues and Profit
- Appendix 4E and Preliminary Financial Report
- Appendix 4C - quarterly
- Media Release - CLINUVEL expands DNA Repair Program
- Appendix 4D Half Yearly Report
Later from Clinuvel Pharmaceuticals
- Appendix 4D Half Year Report
- CLINUVEL Reports December Half Year Operating Results
- afamelanotide in Stroke (AIS) - Positive Preliminary Results
- ACTH Manufacturing Update
- Positive Final Results in Stroke Study CUV801
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals